scholarly journals Performance of the nursing team in the rapid HIV tes

2020 ◽  
Vol 14 ◽  
Author(s):  
Lise Maria Carvalho Mendes ◽  
Leidiane Pereira de Sousa ◽  
Renata Simões Monteiro ◽  
Veridiana Barreto do Nascimento ◽  
Antonio Sabino da Silva Neto
Keyword(s):  
Health Care ◽  
Primary Health Care ◽  
Rapid Test ◽  
Hiv Infections ◽  
Test Method ◽  
Primary Health ◽  
Hiv Test ◽  
Rapid Hiv Test ◽  
Nursing Team ◽  
Anti Hiv

Objetivo: identificar potencialidades e fragilidades da equipe de enfermagem no manejo de pacientes no teste rápido anti-HIV. Método: trata-se de um estudo quantitativo, descritivo, exploratório, com a equipe de enfermagem que atua na execução do teste rápido anti-HIV. Levantou-se amostragem censitária, totalizando seis enfermeiros e seis técnicos de enfermagem os quais responderam ao questionário sociodemográfico e sobre a realização do teste rápido. Resultados: observaram-se, como potencialidades, a realização de grupos educativos, a realização do aconselhamento pós-teste e a entrega de resultados de forma individual. Verificaram-se as seguintes fragilidades: ficha imprópria para a coleta de dados; execução de etapas do teste rápido por profissionais distintos; ambiguidade na execução do protocolo de recrutamento de parceiros e notificação compulsória; sentir-se inseguro para a realização do procedimento; sobrecarga de trabalho; restrição de horários de funcionamento das Unidades Básicas de Saúde. Conclusão: ressalta-se que as fragilidades visualizadas demonstram que não se trata de uma problemática exclusiva à atenção PVHA na perspectiva da Atenção Primária à Saúde, mas, também, a outras ações programáticas no âmbito da Política Nacional da Atenção Básica. Descritores: HIV; Infecções por HIV; Síndrome da Imunodeficiência Adquirida; Equipe de Enfermagem; Atenção Primária à Saúde; Diagnóstico Precoce.AbstractObjective: to identify the nursing team's strengths and weaknesses in the management of patients in the rapid HIV test. Method: this is a quantitative, descriptive, exploratory study, with the nursing team that works on the rapid HIV test. A census sampling was carried out, totaling six nurses and six nursing technicians who answered the sociodemographic questionnaire and the performance of the rapid test. Results: it was observed, as potentialities, the realization of educational groups, the realization of post-test counseling and the delivery of results individually. The following weaknesses were found: improper form for data collection; execution of rapid test steps by different professionals; ambiguity in the execution of the partner recruitment protocol and mandatory notification; feeling insecure to perform the procedure; work overload; restriction of opening hours of the Basic Health Units. Conclusion: it is emphasized that the weaknesses seen demonstrate that this is not an exclusive problem to PLWHA care from the perspective of Primary Health Care, but also to other programmatic actions within the scope of the National Primary Care Policy. Descriptors: HIV; HIV Infections; Acquired Immunodeficiency Syndrome; Nursing, Team; Primary Health Care; Early Diagnosis.ResumenObjetivo: identificar las fortalezas y debilidades del equipo de enfermería en el manejo de pacientes en la prueba rápida de VIH. Método: es un estudio cuantitativo, descriptivo, exploratorio, con el equipo de enfermería que trabaja en la prueba rápida de VIH. Se realizó un muestreo censal, con un total de seis enfermeros y seis técnicos de enfermería que respondieron el cuestionario sociodemográfico y el desempeño de la prueba rápida. Resultados: se observó, como potencialidades, la realización de grupos educativos, la consejería posterior a la prueba y la entrega de resultados individualmente. Se encontraron las siguientes debilidades: forma incorrecta para la recopilación de datos; ejecución de pasos de prueba rápidos por diferentes profesionales; ambigüedad en la ejecución del protocolo de reclutamiento de socios y notificación obligatoria; sentirse inseguro para realizar el procedimiento; sobrecarga de trabajo; restricción de los horarios de atención de las Unidades Básicas de Salud. Conclusión: se enfatiza que las debilidades observadas demuestran que este no es un problema exclusivo para la atención de las PVVS desde la perspectiva de la Atención Primaria de Salud, sino también para otras acciones programáticas dentro del alcance de la Política Nacional de Atención Primaria. Descriptores: VIH; Infecciones por VIH; Síndrome de Inmunodeficiencia Adquirida; Grupo de Enfermeira; Atención Primaria de Salud; Diagnóstico Precoz.

Investigating and implementing change within the primary health care nursing team

1999 ◽  
Vol 30 (1) ◽  
pp. 238-247 ◽  
Author(s):  
Kathleen Galvin ◽  
Clive Andrewes ◽  
Dawn Jackson ◽  
Sarah Cheesman ◽  
Tracy Fudge ◽  
...  
Keyword(s):  
Health Care ◽  
Primary Health Care ◽  
Implementing Change ◽  
Primary Health ◽  
Nursing Team ◽  
Care Nursing

scholarly journals Análise da operacionalização da testagem rápida para o HIV realizada pelo enfermeiro

2020 ◽  
Vol 10 (29) ◽  
pp. 100-111
Author(s):  
Ilisdayne Thallita Soares da Silva ◽  
Dhyanine Morais de Lima ◽  
Wenysson Noleto dos Santos ◽  
Rebecca Stefany da Costa Santos ◽  
Harlon França de Menezes ◽  
...  
Keyword(s):  
Family Health ◽  
Rapid Test ◽  
Structured Interview ◽  
Reference Network ◽  
Health Strategy ◽  
Hiv Test ◽  
Rapid Hiv Test ◽  
Family Health Strategy ◽  
La Red ◽  
Anti Hiv

O estudo objetivou analisar os modos de operacionalização da testagem rápida para o HIV realizada pelo Enfermeiro na Estratégia Saúde da Família. Trata-se de estudo qualitativo com 13 Enfermeiros da Estratégia Saúde da Família da Paraíba. Os dados foram coletados de abril a junho de 2017 por meio de entrevista semiestruturada e analisados pela análise temática de Bardin e o fluxograma descritor. As categorias que emergiram a partir das entrevistas e agrupadas em etapas no fluxograma descritor foram: oferta do teste rápido anti-HIV; entrega do resultado e aconselhamento pré-teste; execução do teste rápido anti-HIV; aconselhamento pós-teste; e encaminhamento do paciente. Conclui-se que a necessidade da identificação do fornecimento adequado de kits de testagem, da ampliação da oferta do teste para a população em geral, e da interação entre as unidades e Rede de referência no Estado.Descritores: Enfermagem, Testes Sorológicos, Síndrome de Imunodeficiência Adquirida. Analysis of the operationalization of the rapid test for HIV carried out by the nurseAbstract: The aim of this study was to analyze the ways in which the nurse performed rapid testing for HIV in the Family Health Strategy. This is a qualitative study with 13 Nurses of the Paraíba Family Health Strategy. The data were collected from April to June 2017 through a semi-structured interview and analyzed by the thematic analysis of Bardin and the flowchart descriptor. The categories that emerged from the interviews and were grouped in stages in the flowchart descriptor were: rapid HIV test offer, delivery of the result and pre-test counseling; implementation of the rapid HIV test; post-test counseling; and patient referral. It is concluded that the need to identify the adequate supply of test kits, the expansion of the test offer to the general population, and the interaction between the units and reference network in the State.Descriptors: Nursing, Serologic Tests, Acquired Immunodeficiency Syndrome. Análisis de la operacionalización de la prueba rápida para el HIV realizado por el enfermeroResumen: El estudio objetivó analizar las formas de operacionalización de las pruebas rápidas para el HIV realizada por el enfermero en la Estrategia de Salud Familiar. Este es un estudio cualitativo con 13 enfermeras de la Estrategia de Salud Familiar de Paraíba. Los datos se recopilaron de abril a junio de 2017 a través de una entrevista semiestructurada y se analizaron mediante el análisis temático de Bardin y el flujograma descriptor. Las categorías que surgieron de las entrevistas y se agruparon en etapas en el flujograma descriptor fueron: oferta de prueba rápida de anti-HIV, entrega del resultado y asesoramiento previo a la prueba; ejecución de la prueba rápida de HIV; asesoramiento posterior a la prueba; y encaminamiento del paciente. Se concluye que la necesidad de identificar el suministro adecuado de kits de prueba, la expansión de la oferta de prueba a la población general y la interacción entre las unidades y la Red de referencia en el Estado.Descriptores: Enfermería, Pruebas Serológicas, Síndrome de Inmunodeficiencia Adquirida.

scholarly journals Weaknesses in primary health care favor the growth of acquired syphilis

2021 ◽  
Vol 15 (2) ◽  
pp. e0009085
Author(s):  
Marquiony Marques dos Santos ◽  
Tatyana Maria Silva de Souza Rosendo ◽  
Ana Karla Bezerra Lopes ◽  
Angelo Giuseppe Roncalli ◽  
Kenio Costa de Lima
Keyword(s):  
Health Care ◽  
Primary Health Care ◽  
Population Size ◽  
Rapid Test ◽  
Multiple Model ◽  
Health Care Teams ◽  
Transmitted Infection ◽  
Partial Coverage ◽  
Primary Health ◽  
Female Condoms

Acquired syphilis is a sexually transmitted infection that affects the general population and has been growing in recent years in many countries. A study was developed aiming to analyze the trends of acquired syphilis associated with sociodemographic aspects and primary health care in Brazil, in the period from 2011 to 2019. This study used secondary data from the national notification systems of the 5570 Brazilian cities and a database of 37,350 primary health care teams, as well as socioeconomic and municipal demographic indicators. The trends of acquired syphilis at the municipal level were calculated from the log-linear regression, crossing them with variables of primary health care and sociodemographic indicators. Finally, a multiple model was built from logistic regression. 724,310 cases of acquired syphilis have been reported. In primary care units, 47.8% had partial coverage and 74.1% had health teams with poor or regular scores. 52.6% had rapid test for syphilis partially available. Male and female condoms are available in 85.9% and 62.9% respectively and 54.4% had penicillin available in the health facility. The increase in trends of acquired syphilis was associated with better availability of the rapid test; lower availability of male condoms; lower availability of female condoms; lower availability of benzathine penicillin; partial coverage of the teams in primary health care; limited application of penicillin in primary health care; higher proportion of teams classified as Poor/Regular in primary health care; higher proportion of women aged 10 to 17 years who had children; higher HDI; higher proportion of people aged 15 to 24 years who do not study, do not work and are vulnerable; and population size with more than 100,000 inhabitants. The following variables remained in the multiple model: not all primary health care teams apply penicillin; higher proportion of primary health care teams with poor/regular scores; population size >100000 inhabitants; partially available female condom. Thus, the weakness of primary health care linked to population size may have favored the growth of the acquired syphilis epidemic in Brazilian cities.

scholarly journals Extrato de Própolis no Combate ao COVID-19: um Relato de Experiência em Nível da Atenção Básica em Saúde

2021 ◽  
Vol 25 (1) ◽  
pp. 85-94
Author(s):  
Leonardo Magela Lopes Matoso ◽  
Mônica Betânia Lopes Matoso
Keyword(s):  
Health Care ◽  
Primary Health Care ◽  
Antiviral Agents ◽  
Signs And Symptoms ◽  
Current Evidence ◽  
International Studies ◽  
Propolis Extract ◽  
Primary Health ◽  
Anti Hiv ◽  
Hiv 1

Em função da alta infectividade e patogenicidade da COVID-19, buscam-se alternativas terapêuticas para tratar e prevenir a doença. Entre essas se  tem o extrato de própolis. Este estudo objetiva descrever a utilização do extrato de própolis na Atenção Primária em Saúde durante a Pandemia da COVID-19 como método nutracêutico capaz de potencializar sistema imunológico e prevenir contra a infecção. Trata-se de estudo qualitativo, descritivo e exploratório, do tipo relato de experiência a respeito de ações e de estratégias contingenciais/emergenciais adotados na APS. Para subsidiar a discussão foram apreciados 59 estudos nacionais e internacionais, obtidos em bases de dados científicas. Estudos defendem que o própolis possui ação antiviral, anti-inflamatória, anticancerígena, anticonceptiva, anti-HIV 1, antibactericida, bacteriostático, cicatricial, antiparasitária, imunomoduladora e anti-SARS e anti-COV-2, o que pode tornar esse produto um recurso complementar para tratamento da Síndrome da Angústia Respiratória Aguda provocada pela COVID-19. Observou-se que ao prescrever 30 gotas de extrato de própolis, duas vezes ao dia, para indivíduos com diagnóstico de COVID-19, apresentando tosse seca, febre, cansaço, dores de cabeça e perda de paladar e olfato; tem-se verificado que com três dias de uso do extrato de própolis, os sinais e sintomas têm diminuído, significativamente, ao ponto de relatarem se sentirem bem, e sem a doença. Acredita-se que o extrato de própolis seja eficiente contra COVID-19, podendo contribuir com desenvolvimento de novas tecnologias de tratamento em saúde ou desenvolvimento de novos agentes antivirais eficazes e seguros. Mais estudos acerca da própolis e sua ação contra COVID-19 precisam ser realizados, entretanto, isso não diminui sua comprovação atual.   Palavras-chaves: Pandemia. Nutracêuticos. Extrato de Própolis. Atenção Primária à Saúde.   Abstract Due to the high infectivity and pathogenicity of COVID-19, therapeutic alternatives have been sought to treat and prevent the disease. Among these, there is the propolis extract. This study aims to describe the use of propolis extract in Primary Health Care during the COVID-19 pandemic as a nutraceutical method capable of enhancing the immune system and preventing infection. This is a qualitative, descriptive, and exploratory study, of the experience report type regarding contingency / emergency actions and strategies adopted in PHC. To support the discussion, 59 national and international studies obtained from scientific databases were evaluated. Studies argue that propolis has antiviral, anti-inflammatory, anticancer, anticonceptive, anti-HIV 1, antibacterial, bacteriostatic, healing, antiparasitic, immunomodulatory and anti-SARS and anti-VOC-2 properties, which can make this product a resource complementary treatment for the Acute Respiratory Distress Syndrome caused by COVID-19. It was observed that when prescribing 30 drops of propolis extract twice a day for individuals diagnosed with COVID-19, presenting dry cough, fever, tiredness, headaches and loss of taste and smell, it was verified that after three days  using  propolis extract, the signs and symptoms  decreased significantly, to the point of reporting feeling well, and without the disease. Propolis extract is believed to be effective against COVID-19 and may contribute to the development of new health treatment technologies or the development of new effective and safe antiviral agents. Further studies on propolis and its action against COVID-19 need to be carried out, however, this does not diminish its current evidence.   Keywords: Pandemic. Nutraceuticals. Propolis Extract. Primary Health Care.

scholarly journals Strengths and weaknesses of rapid hiv test implementation in a specialized center in Brazil

2018 ◽  
Vol 20 (5) ◽  
pp. 560-567
Author(s):  
Adolfo Pizzinato ◽  
Kátia Bones Rocha ◽  
Rodrigo De Oliveira-Machado ◽  
Fernanda Torres de Carvalho ◽  
Isadora Nogueira-Freire
Keyword(s):  
Health Care ◽  
Hiv Testing ◽  
Health Care Access ◽  
Health Care Professionals ◽  
Rapid Test ◽  
Service Users ◽  
Structured Interviews ◽  
Rapid Hiv Testing ◽  
Hiv Test ◽  
Rapid Hiv Test

Objective To analyze how health professionals and health service users assess counseling on Rapid HIV test, as well as its implementation, which started in Brazil in 2010, focusing on positive aspects, barriers, and limitations, and analyzing possible meanings that are given to STD and HIV/AIDS.Method Qualitative, exploratory, and descriptive research. Semi-structured interviews were administered to 27 service users and 14 health care professionals; a thematic analysis of the interviews was performed. The study was carried out in one of the first Counseling and Testing Centers (CTC) designed to implement Rapid HIV tests in Porto Alegre, Brazil.Results Positive aspects of Rapid HIV testing implementation included a reduced waiting time for obtaining the test results, better assistance provision, an increase in the number of service hours, personalized pre- and post-tests, and better prepared health care professionals regarding health care during counseling. Limitations included beliefs about the effectiveness of Rapid HIV testing, physical structure, bad publicity on this technology, and poor health care capacity. Likewise, there are some who oppose this type of test, since they believe rapid tests may not be effective.Conclusions Integrating the perspectives of health care professionals and users on this policy will favor future rapid test implementations in other CTCs, and increase health care access possibilities.

scholarly journals HUBUNGAN UMUR DAN JENIS KELAMIN TERHADAP KEBERHASILAN PITC (PROVIDER INITIATED TESTING AND COUNSELLING) PADA PASIEN TB DI KOTA MEDAN TAHUN 2017

2019 ◽  
Vol 13 (2) ◽  
Author(s):  
Sity Kunarisasi ◽  
Imran Pambudi ◽  
Asri Mutiara Putri ◽  
Nurhanifah Hamdah
Keyword(s):  
Health Care ◽  
Primary Health Care ◽  
Public Health Issue ◽  
P Value ◽  
Chi Square ◽  
Cross Sectional ◽  
Primary Health ◽  
Hiv Test ◽  
Chi Square Test ◽  
And Gender

Tuberculosis is a public health issue. Prevalence of tuberculosis in 2017 is estimated 824.000 cases in which making Indonesia the third country in the world with biggest burden TB and the seventh country with biggest burden in HIV-TB. PITC in primary health care is a Health Ministry program. PITC is the only test and counseling to motivated TB patient to get HIV test. The aim of this study is to analyze relationship between age and gender with the success of PITC in TB patients to know the HIV status at Medan in 2017. Method This research is a descriptive-analytic study with cross-sectional approach. the population in this study is TB patients with age 15-49 years old wo had TB diagnosed either with bacteriologic or clinical in primary health care at Medan in 2017. Medan is chosen because Medan is one of eight cities with the highest burden of TB and HIV in Indonesia, also it has complete recording of TB patients. The sample of this study is all TB patients in primary health care at Medan in 2017 who had PITC in total 2.228 from all TB patients in total 5.039 patients. Data analysis using SPSS to search for p value and Odds Ratio (OR). Result 250 of 2.228 (11,22%) patients is positive in HIV test. Statistics analysis using chi-square test shows p value 0.000 (p<0.05) and OR = 1.905 for relationship between gender and HIV test positive. Also, p value of 0,006 (p<0,05) and OR = 1.459 for relationship between age and HIV test positive. In this study with the implementation of PITC in TB patients in primary health care at Medan there is a relationship between sex and age with HIV infection.

scholarly journals Extrato de Própolis no Combate ao COVID-19: um Relato de Experiência em Nível da Atenção Básica em Saúde

UNICIÊNCIAS ◽  
2021 ◽  
Vol 24 (1) ◽  
pp. 94-103
Author(s):  
Leonardo Magela Lopes Matoso ◽  
Mônica Betania Lopes Matoso
Keyword(s):  
Health Care ◽  
Primary Health Care ◽  
Antiviral Agents ◽  
Signs And Symptoms ◽  
Current Evidence ◽  
International Studies ◽  
Propolis Extract ◽  
Primary Health ◽  
Anti Hiv ◽  
Hiv 1

Em função da alta infectividade e patogenicidade da COVID-19, buscam-se alternativas terapêuticas para tratar e prevenir a doença. Entre estas se tem o extrato de própolis. Esse estudo objetiva descrever a utilização do extrato de própolis na Atenção Primária em Saúde durante pandemia da COVID-19 como método nutracêutico capaz de potencializar sistema imunológico e prevenir contra a infecção. Trata-se de estudo qualitativo, descritivo e exploratório, do tipo relato de experiência a respeito de ações e estratégias contingenciais/emergenciais adotados na APS. Para subsidiar discussão foram apreciados 59 estudos nacionais e internacionais obtidos em bases de dados científicas. Estudos defendem que o própolis possui ação antiviral, anti-inflamatória, anticancerígena, anticonceptiva, anti-HIV 1, antibactericida, bacteriostático, cicatricial, antiparasitária, imunomoduladora e anti-SARS e anti-COV-2, o que pode tornar esse produto um recurso complementar para tratamento da Síndrome da Angústia Respiratória Aguda provocada pela COVID-19. Observou-se que ao prescrever 30 gotas de extrato de própolis, duas vezes ao dia, para indivíduos com diagnóstico de COVID-19, apresentando tosse seca, febre, cansaço, dores de cabeça e perda de paladar e olfato; tem-se verificado que com três dias de uso do extrato de própolis, os sinais e sintomas têm diminuído significativamente, ao ponto de relatarem sentirem-se bem, e sem a doença. Acredita-se que extrato de própolis é eficiente contra COVID-19, podendo contribuir com desenvolvimento de novas tecnologias de tratamento em saúde ou desenvolvimento de novos agentes antivirais eficazes e seguros. Mais estudos acerca da própolis e sua ação contra COVID-19 precisam ser realizadas, entretanto, isso não diminui sua comprovação atual.   Palavras-chave: Pandemia. Nutracêuticos. Extrato de Própolis. Atenção Primária à Saúde.   Abstract Due to the high infectivity and pathogenicity of COVID-19, therapeutic alternatives are sought to treat and prevent the disease. Among these, there is the propolis extract. This study aims to describe the use of propolis extract in Primary Health Care during the COVID-19 pandemic as a nutraceutical method capable of enhancing the immune system and preventing infection. This is a qualitative, descriptive, and exploratory studytype regarding contingency / emergency actions and strategies adopted in PHC. To support the discussion, 59 national and international studies obtained from scientific databases were evaluated. Studies argue that propolis has antiviral, anti-inflammatory, anticancer, anticonceptive, anti-HIV 1, antibacterial, bacteriostatic, healing, antiparasitic, immunomodulatory and anti-SARS and anti-VOC-2 properties, which can make this product a resource complementary treatment for the Acute Respiratory Distress Syndrome caused by COVID-19. It was observed that when prescribing 30 drops of propolis extract twice a day for individuals diagnosed with COVID-19, presenting dry cough, fever, tiredness, headaches and loss of taste and smell, it was verified that after three days using  propolis extract, the signs and symptoms decreased significantly, to the point of reporting feeling well, and absence of t the disease. Propolis extract is believed to be effective against COVID-19 and may contribute to the development of new health treatment technologies or the development of new effective and safe antiviral agents. Further studies on propolis and its action against COVID-19 need to be carried out, however, this does not diminish its current evidence.   Keywords: Pandemic. Nutraceuticals. Propolis Extract. Primary Health Care.

Sign in / Sign up

Export Citation Format

Share Document